Company Filing History:
Years Active: 2017-2021
Title: **Innovator Spotlight: Magnus Doverskog from Stockholm**
Introduction
Magnus Doverskog is a prominent inventor based in Stockholm, Sweden, known for his significant contributions to pharmaceutical formulations. With a total of five patents to his name, Doverskog has made strides in areas that are crucial for medical advancements.
Latest Patents
His latest inventions include a novel pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime. This innovative formulation comprises 0.1-10% by weight of the active compound along with a vehicle that contains 45-100% of a monoester and optional diester and triester components. The formulation is particularly noteworthy for its potential use in treating medical conditions such as hypersomnia and hepatic encephalopathy.
Career Highlights
Doverskog currently works with Umecrine Cognition AB, a company recognized for its focus on innovative pharmaceuticals. His work has contributed to the development of critical treatments, making him a valued member of the research community in the pharmaceutical sector.
Collaborations
Throughout his career, Doverskog has collaborated with notable coworkers including Torbjörn Bäckström and Maja Johansson. These collaborations have facilitated rich exchanges of ideas and furthered the impact of their collective innovations in the field of pharmacology.
Conclusion
Magnus Doverskog stands out as an inventor dedicated to advancing pharmaceutical science. His innovative formulations and collaborative efforts reflect a commitment to improving medical treatments, underscoring the essential role of inventors in driving progress in healthcare.